|
Conference Co-Chairs:
Susan Windham-Bannister, Ph.D., President and CEO, Massachusetts
Life Sciences Center
Thomas J. Sommer, President MassMEDIC
Imran Nasrullah, Chief Business Officer, Massachusetts Biotechnology Council
Speaking Faculty:
Dan Rippy, President & CEO, Allegro Diagnostics
Gregg Mayer, Vice President, Diagnostic Strategy, BG Medicine
Timothy Pratt, Executive Vice President, Secretary and General Counsel,
Boston Scientific Corporation
Michael Dunkley, Vice President, Medical Technology, Cambridge Consultants
Tom Hutchinson, Vice President, Quality Assurance, Regulatory & Clinical
Affairs, Davol, Inc., CR Bard
Joan Keutzer, Vice President, Scientific Affairs Genzyme Corporation
Ann Merrifield, President, Genzyme Biosurgery
David Dykeman, Shareholder, Greenberg Traurig
Susan Posner, Vice President, Health Advances
Kristin Pothier, Vice President, Health Advances
David Fox, Partner, Hogan & Hartson LLP
John Evans, Director of Product Development, Infinity Pharmaceuticals
Randolph Hubbel, Worldwide Vice President, Worldwide Marketing,
Wound Management, Johnson & Johnson
Wil Chao, Director, Marketing & Business Development, Advanced Technologies and Regenerative Medicine, LLC (ATRM)
Maren Anderson, President, MDA Consulting
Reid Leonard, Executive Director, External Research & Licensing, Merck Research Laboratories, Merck & Co., Inc.
Maggie Pax, Vice President, Business Development, MicroCHIPS
Nandan Padukone President & CEO, Nuvera Biosciences
Joseph J. Leghorn, Partner, Nixon Peabody
Mohit Kaushal, Polaris Ventures
Amir Nashat, Polaris Venture Partners
Kevin M. Quinley, CPCU, ARM, AIC, AIM Are
Hans Hofstraat, Vice President,
Philips Research Laboratories
Sharad Rastogi, Director, Life Sciences & Healthcare Practice, PRTM
Michael Steele, Vice President, Business Development, SeraCare Life Sciences
Dean Falb, Vice President, Research & Development, Stryker Biotech
John McDonough, Chief Executive Officer, T2 Biosystems
Gary Sender, CFO, Tengion
Stephen McCarthy, M2D2 Co-Director, UMass Lowell
|
